Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis.
hematology
myelofibrosis
myeloid sarcoma
oncology
pathology
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
20
02
2019
revised:
17
07
2019
accepted:
12
08
2019
entrez:
3
12
2019
pubmed:
4
12
2019
medline:
4
12
2019
Statut:
epublish
Résumé
Immunophenotyping is critical to the diagnosis of MS, as it can be difficult to differentiate from other diagnoses including lymphoma using conventional light microscopy.
Identifiants
pubmed: 31788302
doi: 10.1002/ccr3.2473
pii: CCR32473
pmc: PMC6878033
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2274-2276Informations de copyright
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
CCC has received honoraria from Abbvie, H3 Biomedicine, and Pharmacyclics, has served as a consultant for Abbvie, has received institutional funding from Gilead, H3 Biomedicine, and Incyte, and has received travel funding from AROG and Incyte, JFZ has received honoraria from Celgene, Tolero, and Agios, has served as a consultant for Celgene and AsystBio Laboratories, and has received research funding from Merck, Takeda, and Tolero, and NDM received free sequencing from ArcherDx, and received prior research and travel funding from Ventana Biosystems, a subsidiary of Roche.
Références
Leuk Lymphoma. 2006 Dec;47(12):2527-41
pubmed: 17169797
Leukemia. 2007 Feb;21(2):340-50
pubmed: 17170724
Clin Case Rep. 2019 Oct 04;7(11):2274-2276
pubmed: 31788302